Final report of second quarter financial results
Cognigen quarterly profits rise
Consolidated net revenues up 48.4%; second quarter net income increases 19.8%
Simulations Plus Reports First Quarter FY2015 Financial Results
Final report of first quarter financial results after Cognigen merger; net revenues up 54%; gross profit increased 41%
Simulations Plus Sets Date for 1st Quarter 2015 Earnings Release and Conference Call
Conference Call to be on Wednesday, January 14, at 4:15 PM ET
Simulations Plus Reports First Quarter FY2015 Preliminary Revenues
Preliminary revenues increase 50% to first quarter record $3.96 million
Simulations Plus Reports FY2014 and Fourth Quarter FY2014 Financial Results
Full Fiscal Year Pharmaceutical Software and Services up 13.8%, Fourth Quarter Revenues up 27.4%
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2014 Earnings Release and Conference Call
Conference Call to be on Tuesday, November 25, 2014, at 4:15 PM EST
Simulations Plus Announces Changes in Board of Directors
Dr. John Paglia, Ph.D., CFA, CPA to Replace Mr. Harold Wayne Rosenberger Retiring after 7 Years on Board
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
Cash dividend yield of 3.3% to be distributed in November
Simulations Plus Adds to Portfolio with Release of MembranePlus
First Release of New Product in 10 Years; Provides Unique In Vitro Permeability Capabilities and Creates Cross-Selling Opportunities
Simulations Plus Wins Cooperative Agreement with FDA
$200,000 Grant to Support Enhancements to Company’s Industry-Leading GastroPlus Software
Simulations Plus Releases GastroPlus Version 8.6
Interim release adds several user-requested functions